Literature DB >> 21108670

Pregnancy outcomes in women with moderate-to-severe psoriasis.

E Cohen-Barak1, Z Nachum, D Rozenman, M Ziv.   

Abstract

BACKGROUND: The association between psoriasis and pregnancy outcomes has not been adequately examined, although psoriasis onset is common in the reproductive period.
OBJECTIVE: To evaluate the association between moderate-to-severe psoriasis and pregnancy complications.
METHODS: A retrospective, matched cohort study of 68 deliveries in 35 women with moderate-to-severe psoriasis compared to 237 deliveries in 236 women without psoriasis randomly selected after matching for age, parity and gestational age.
RESULTS: The psoriasis patients had higher mean of past spontaneous (0.42±0.58 vs. 0.26±0.63, P=0.002) and induced (0.32±0.60 vs. 0.06±0.25, P=0.001) abortions than controls. They had a higher percentage of pregnancy-induced hypertensive diseases (7.4% vs. 2.1%, P<0.05) and premature rupture of membranes (16% vs. 5.5%, P<0.008). Newborns to women with psoriasis had higher birth weight (3375±543 g vs. 3247±460 g, P=0.03), increased percentage of large-for-gestational age (24% vs. 12%, P=0.02), and macrosomia (13% vs. 4.2%P=0.02). In multivariate analysis, moderate-to-severe psoriasis was an independent risk factor for previous spontaneous abortions, induced abortions, premature rupture of membranes (PROM), and newborn macrosomia.
CONCLUSION: Moderate-to-severe psoriasis is associated with spontaneous and induced abortions, pregnancy-induced hypertensive diseases, premature rupture of membranes, large-for-gestational age newborns, and macrosomia.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2010        PMID: 21108670     DOI: 10.1111/j.1468-3083.2010.03917.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  13 in total

1.  No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis.

Authors:  Elise Harder; Anne-Marie Nybo Andersen; Mads Kamper-Jørgensen; Lone Skov
Journal:  J Invest Dermatol       Date:  2014-01-24       Impact factor: 8.551

2.  Associations of maternal atopic diseases with adverse pregnancy outcomes: a national cohort study.

Authors:  Håvard Trønnes; Allen J Wilcox; Trond Markestad; Mette Christophersen Tollånes; Rolv Terje Lie; Dag Moster
Journal:  Paediatr Perinat Epidemiol       Date:  2014-10-30       Impact factor: 3.980

3.  [Psoriasis therapy in pregnancy : Consultation of pregnant patients].

Authors:  B Stephan; M A Radtke; M Augustin
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

Review 4.  Oversight and Management of Women with Psoriasis in Childbearing Age.

Authors:  Ștefana Bucur; Alexandra-Petruța Savu; Ana Maria Alexandra Stănescu; Elena-Daniela Șerban; Alin-Codruț Nicolescu; Traian Constantin; Anca Bobircă; Maria-Magdalena Constantin
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

5.  Spontaneous abortion during ustekinumab therapy.

Authors:  Christina Fotiadou; Elizabeth Lazaridou; Eleni Sotiriou; Demetrios Ioannides
Journal:  J Dermatol Case Rep       Date:  2012-12-31

6.  Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark.

Authors:  Cæcilie Bachdal Johansen; Alexander Egeberg; Espen Jimenez-Solem; Lone Skov; Simon Francis Thomsen
Journal:  JAAD Int       Date:  2022-04-19

Review 7.  Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis.

Authors:  Dario Kivelevitch; Bobbak Mansouri; Alan Menter
Journal:  Biologics       Date:  2014-04-17

Review 8.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

9.  Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.

Authors:  Megan E B Clowse; Steven R Feldman; John D Isaacs; Alexandra B Kimball; Vibeke Strand; Richard B Warren; Daniel Xibillé; Yan Chen; Donald Frazier; Jamie Geier; James Proulx; Amy Marren
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

Review 10.  The role of hormones in the pathogenesis of psoriasis vulgaris.

Authors:  Iulia Ioana Roman; Anne-Marie Constantin; Mihaela Elena Marina; Remus Ioan Orasan
Journal:  Clujul Med       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.